Medifast Inc (MED)

SG&A Expenses

$238.96M

TTM · Period ending: · USD

MED logo

MED SG&A Expenses

Latest reported$238.96M
MED TTM SG&A Expenses ($7.90M → $238.96M)
High-resolution chart · PNG

MED sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Medifast Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
238,957,000
258,944,000
289,400,000
316,967,000
354,295,000
407,899,000
441,744,000
486,927,000
535,227,000
575,922,000
649,449,000
717,754,000
800,579,000
901,288,000
955,608,000
986,059,000
1,003,252,000
962,807,000
911,356,000
841,178,000
748,769,000
647,697,000
563,656,000
511,746,000
474,940,000
457,094,000
445,819,000
425,746,000
392,809,000
351,143,000
310,836,000
271,188,000
229,410,000
204,022,000
188,180,000
179,008,000
174,262,000
176,162,000
178,805,000
178,021,000
175,996,000
172,299,000
172,631,000
154,745,000
157,704,000
158,913,000
159,968,000
188,802,000
202,162,000
218,738,000
234,256,000
242,829,000
244,733,000
247,986,000
244,773,000
236,227,000
226,551,000
210,993,000
196,953,000
187,935,000
179,614,000
169,840,000
160,829,000
148,691,000
135,794,000
121,609,000
105,652,000
94,243,000
84,092,000
76,518,000
71,915,000
67,305,000
63,708,000
60,490,000
56,516,000
54,076,000
52,476,000
49,994,000
48,312,000
43,999,000
37,877,000
31,904,000
25,894,000
22,921,000
20,732,000
18,383,000
17,590,000
17,601,000
16,895,000
16,284,000
14,956,000
14,581,000
11,755,000
9,315,000
6,906,000
4,020,000
3,321,000
2,445,000
2,066,000
1,941,195
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.